4 курс / Дерматовенерология / Клинические_рекомендации_по_ведению_больных_инфекциями,_передаваемыми
.pdf
151.Stamm WE, Hicks CB, Martin DH, et al. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. Jama 1995 Aug 16;274(7):545-9.
152.Stokes T, Schober P, Baker J, et al. Evidence-based guidelines for the management of genital chlamydial infection in general practice. (Leicestershire Chlamydia Guidelines Group). Family practice 1999 Jun;16(3):269-77.
153.Street E, Joyce A, Wilson J. BASHH UK guideline for the management of epididymo-orchitis, 2010. International journal of STD & AIDS 2011 Jul;22(7):361-5.
154.Svenstrup HF, Fedder J, Kristoffersen SE, Trolle B, Birkelund S, Christiansen G. Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility--a prospective study. Fertility and sterility 2008 Sep;90(3):513-20.
155.Sweet RL. Treatment strategies for pelvic inflammatory disease. Expert opinion on pharmacotherapy 2009 Apr;10(5):823-37.
156.Taylor-Robinson D, Renton A, Jensen JS, et al. Association of Mycoplasma genitalium with acute non-gonococcal urethritis in Russian men: a comparison with gonococcal and chlamydial urethritis. International journal of STD & AIDS 2009 Apr;20(4):234-7.
157.Thin RN, Symonds MA, Booker R, Cook S, Langlet F. Double-blind comparison of a single dose and a five-day course of metronidazole in the treatment of trichomoniasis. // Br J Vener Dis. 1979 Oct;55(5):354-6.
158. US Food and Drug Administration. Potential Signals of Serious Risks/ New Safety Information Identified by the Adverse Event Reporting System (AERS) between January – March 2010. Available at: http:/ /www.fda. gov/ Drugs /Guidance Compliance Regulatory Information/Surveillance/ AdverseDrugEffects/ucm216272.htm. Accessed 25 July.
159. Vermeulen GM, van Zwet AA, Bruinse HW Changes in the vaginal flora |
|
||
after two percent clindamycin vaginal cream in women at high risk of |
|
||
spontaneous preterm birth. British Journal of Obstetrics & Gynaecology |
|
||
2001 Jul VL:108 NO:7 P:697-700. |
|
литературы |
|
161. W. Buck H J. Warts (genital). Clinical evidence 2010;2010. |
|
||
160. von Krogh G, Lacey CJ, Gross G, Barrasso R, Schneider A. European |
|
||
guideline for the management of anogenital warts. International journal of |
|
||
STD & AIDS 2001 Oct;12 Suppl 3:40-7 |
|
Список |
|
162. Wald, A, Benedetti, J, Davis, G, et al. A randomized, |
double-blind, |
||
|
|||
comparative trial comparing high-and standard-dose oral acyclovir for first-
111
episode genital herpes infections. Antimicrob Agents Chemother 1994; 38:174.
163. Wei H, Chen Z, Xu P, Ma YG, Xu LJ. Effect of Jieze No.1 on cervicitis caused by ureaplasma urealyticum and on ureaplasma urealyticum in vitro. Chinese journal of integrative medicine 2008 Jun;14(2):88-93.
164. WHO 2006. Global strategy for the prevention and control of sexually transmitted infections: 2006-2015: breaking the chain of transmission. Available at: http://whqlibdoc.who.int/publications/2007/9789244563472_ rus.pdf. last access 19, Sept 2010.
165. Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010 Dec 17;59(RR-12):1-110.
166. Yasuda M, Maeda S, Deguchi T. In vitro activity of fluoroquinolones against Mycoplasma genitalium and their bacteriological efficacy for treatment of M. genitalium-positive nongonococcal urethritis in men. Clin Infect Dis 2005 Nov 1;41(9):1357-9.
167. Yokoi S, Maeda S, Kubota Y, et al. The role of Mycoplasma genitalium and Ureaplasma urealyticum biovar 2 in postgonococcal urethritis. Clin Infect Dis 2007 Oct 1;45(7):866-71.
168. Young H., Pryde J., Duncan L., Dave J. The Architect Syphilis assay for antibodies to Treponema pallidum: an automated screening assay with high
Инфекции, передаваемые половымпутем |
sensitivity in primary syphilis. Sex Transm Infect 2009; 85: 19-23. |
|
112